Podovirus
by Jessica Sacher and Joseph Campbell
Cystic Fibrosis Doctor Discusses Phage Therapy
About this podcast
Phages (bacteriophages) are viruses that kill bacteria with sniper-like precision. They can be incredibly useful for treating life-threatening infections ('phage therapy'), and can help us reduce our dependence on antibiotics. They've been known for 100 years... so WHY do we still not see them on the shelves?
Jessica Sacher, PhD (Staff Scientist at Stanford and cofounder of Phage Directory) and Joseph Campbell, PhD (former NIAID program officer) talk to phage therapy practitioners, researchers and entrepreneurs to understand one question: why don't we have phage therapy yet?
Episodes
The newest 20 of 22 episodes
- Cystic Fibrosis Doctor Discusses Phage Therapy · 54 minAn interview with Jerry Nick, a professor at National Jewish Health!
- Discussion of ASM and Phage Therapy · 38 minAn interview with American Society for Microbiology (ASM) members Dev Mittar and Neha Prasad discussing ASM and phage therapy!
- Phage Therapy: The Next Challenge in a Career Full of Challenges · 47 minAn interview with Deborah Birx discussing phage therapy!
- Discussion of Phage Therapy for CF Patients - Rebekah Dedrick · 39 minRebekah Dedrick shares her background in phage research and her transition to the Cystic Fibrosis (CF) Foundation. She explains how her work with mycobacteriophages intersected…
- Cell-free synthesis for the clinic: How Invitris is building a phage printer · 54 min · Season 1 Episode 17What if you could build biology in a tube, no cells required? Invitris is a Munich-based cell-free synthesis company starting with bacteriophages. Kilian Vogele, co-founder of…
- Why phage companies aren’t raising $400M rounds… yet | Paul Garofolo · 1 h 2 min · Season 1 Episode 16“The thing everybody thinks is a tailwind for our space — the low financial barrier to get into a clinical trial — is actually one of the largest headwinds.” Paul has spent 35…
- Chip Schooley & Graham Hatfull: the state of phage therapy (& what HIV can teach us) · 1 h 6 min · Season 1 Episode 15Chip Schooley (UC San Diego, IPATH) and Graham Hatfull (University of Pittsburgh) join us to discuss why phage therapy needs biologists and clinicians collaborating — and what…
- How to run a phage therapy center from your academic lab · 54 min · Season 1 Episode 14What does it take to build a phage therapy program from nothing — and keep your research lab running at the same time? In this episode, Joe and I sat down with Dr. Daria Van…
- AI-generated phages that work: ChatGPT for phage biologists? · 1 h 3 min · Season 1 Episode 13Can AI design living organisms from scratch? Samuel King and Claudia Driscoll from the Arc Institute used genome language models to generate functional phages—and 16 of them…
- How to get successful outcomes with phage therapy: Saima Aslam, MD, MS · 54 min · Season 1 Episode 12"When I first started, I was treating anything and everything in terms of ‘this is highly drug resistant and it's failed’. But I think I have a clearer idea now, at least…
- Dr. Marisa Azad, MD, PhD: Behind Canada's first prosthetic joint treatment with phage therapy · 49 min · Season 1 Episode 11"It's unacceptable to just tell this poor patient, there's nothing I can do to help you... That's when I thought, okay, well, what about kind of pushing the boundaries a bit here…
- How to navigate regulatory limbo: a Canadian phage therapy CEO's playbook · 60 min · Season 1 Episode 10"Phages are not drugs. Every time they say, 'Did you go through regulatory?' I say, 'I can do regulatory, but I'm not a drug.' There's 145 components of the regulatory…
- Why can't patients access phage therapy? Does FDA need to change, or do patients just need a voice? · 1 h 12 min · Season 1 Episode 9"This feels just like the early days of the HIV crisis. People are dying, you're not hearing about it. We need a group like ACT UP to bring this to the public. We're not going to…
- Finally, phase 2 data! Inside BiomX's successful phage therapy trial with CEO Jonathan Solomon · 58 min · Season 1 Episode 8"Finally, finally we have Phase 2 data. We put a dent in the theory that phage therapy doesn't work. Maybe it does work. Maybe it's worth taking a risk." Jonathan Solomon joins…
- Does every scientist need an AI co-scientist? How two professors solved a years-long viral mystery · 1 h 9 min · Season 1 Episode 7"I was so biased. I knew too much and that's why we couldn't see the obvious answer that was right in front of us for years." In this episode of the Podovirus Podcast, we…
- What's the business case for phage therapy? · 51 min · Season 1 Episode 6“Getting our foot through the door to any VC... As soon as they hear we're infectious disease, their eyes kind of get big. And then they hear we're antibacterial, their eyes get…
- How to bring phages to market: Intralytix's food-to-pharma strategy · 60 min · Season 1 Episode 5"Somebody's father, friend, husband just passed away in the most developed country in the world... from a simple infection that probably could have been treated in Georgia." In…
- Gina Suh, MD: What it's really like to treat patients with phage therapy · 1 h 12 min · Season 1 Episode 4What's it like to be a doctor treating patients with phage therapy in the US today? Dr. Gina Suh, Mayo Clinic infectious disease physician, tells us: - How she established…
- Jesus Fernandez-Rodriguez: How Eligo Bioscience edits gut bacteria with phages · 57 min · Season 1 Episode 3Welcome to the Podovirus podcast, episode 3! In this episode, I talk with Jesus Fernandez-Rodriguez from Eligo Bioscience, a Paris-based biotech company pioneering microbiome…







